Lam Research Corporation (NASDAQ:LRCX) Receives Average Recommendation of “Moderate Buy” from Brokerages

Lam Research Corporation (NASDAQ:LRCX) has earned a consensus recommendation of “Moderate Buy” from the thirty-six ratings firms that are currently covering the company, MarketBeat reports. Ten analysts have rated the stock with a hold recommendation and twenty-six have assigned a buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $152.8733.

LRCX has been the topic of a number of research reports. Needham & Company LLC raised their target price on shares of Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Weiss Ratings reissued a “buy (b)” rating on shares of Lam Research in a research note on Monday, December 1st. Evercore ISI raised their price objective on Lam Research from $115.00 to $170.00 and gave the stock an “outperform” rating in a report on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft lifted their target price on Lam Research from $150.00 to $160.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Finally, Zacks Research downgraded Lam Research from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 24th.

Lam Research Stock Up 1.0%

Shares of LRCX opened at $158.70 on Friday. The firm has a market capitalization of $199.33 billion, a P/E ratio of 34.96, a P/E/G ratio of 1.63 and a beta of 1.77. Lam Research has a 12-month low of $56.32 and a 12-month high of $167.15. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The firm has a fifty day moving average price of $150.02 and a 200-day moving average price of $117.35.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter last year, the firm posted $0.86 EPS. The firm’s revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities research analysts expect that Lam Research will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.7%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio is presently 22.91%.

Insider Buying and Selling at Lam Research

In related news, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the transaction, the director directly owned 1,652 shares of the company’s stock, valued at $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at $148,677,892.20. This trade represents a 3.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 102,608 shares of company stock worth $14,916,496. Company insiders own 0.31% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. IMG Wealth Management Inc. bought a new stake in Lam Research during the second quarter valued at about $26,000. Stance Capital LLC bought a new stake in shares of Lam Research in the 3rd quarter valued at about $26,000. Howard Hughes Medical Institute bought a new stake in shares of Lam Research in the 2nd quarter valued at about $27,000. Triumph Capital Management purchased a new position in shares of Lam Research in the 3rd quarter worth approximately $27,000. Finally, Strategic Wealth Investment Group LLC bought a new position in shares of Lam Research during the 2nd quarter worth approximately $29,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.